I agree that this site is using cookies. You can find further informations here.
X
Kågedal, Matts
51  results:
Search for persons X
?
1

Simulation‐based evaluation of personalized dosing approach..:

Yoshida, Kenta ; Poon, Victor ; Dash, Ajit...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  4 - p. 544-550 , 2024
Link: https://doi.org/10.1002/..
 
?
2

gPKPDviz: A flexible R shiny tool for pharmacokinetic/pharm..:

Lu, Tong ; Poon, Victor ; Brooks, Logan...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2023)  3 - p. 341-358 , 2023
Link: https://doi.org/10.1002/..
 
?
3

A disease model predicting placebo response and remission s..:

Moein, Anita ; Langenhorst, Jurgen ; Plan, Elodie L....
Clinical and Translational Science.  16 (2023)  11 - p. 2310-2322 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Support to early clinical decisions in drug development and..:

Bruno, René ; Chanu, Pascal ; Kågedal, Matts...
British Journal of Cancer.  129 (2023)  9 - p. 1383-1388 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Population Pharmacokinetics of Ranibizumab Delivered via th..:

Kågedal, Matts ; Alskär, Oskar ; Petersson, Klas...
The Journal of Clinical Pharmacology.  63 (2023)  11 - p. 1210-1220 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Pharmacokinetics of the Port Delivery System with Ranibizum..:

Wykoff, Charles C. ; Campochiaro, Peter A. ; Pieramici, Dante J....
Ophthalmology and Therapy.  11 (2022)  5 - p. 1705-1717 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Assessment of pharmacokinetic linearity after repeated drug..:

Bauer, Alexander ; Kagedal, Matts ; Wolfsegger, Martin J.
Pharmaceutical Statistics.  21 (2022)  5 - p. 932-943 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Population pharmacokinetic and exploratory exposure–respons..:

Wang, Bei ; Deng, Rong ; Hennig, Stefanie...
Cancer Chemotherapy and Pharmacology.  88 (2021)  3 - p. 499-512 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Model‐Informed Therapeutic Dose Optimization Strategies for..:

Liao, Michael Z. ; Lu, Dan ; Kågedal, Matts...
Clinical Pharmacology & Therapeutics.  110 (2021)  5 - p. 1216-1230 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Correction to: Population pharmacokinetic and exploratory e..:

Wang, Bei ; Deng, Rong ; Hennig, Stefanie...
Cancer Chemotherapy and Pharmacology.  89 (2021)  4 - p. 571-572 , 2021
Link: https://doi.org/10.1007/..
 
?
11

A longitudinal model for the Mayo Clinical Score and its su..:

Kawakatsu, Sonoko ; Zhu, Rui ; Zhang, Wenhui...
Journal of Pharmacokinetics and Pharmacodynamics.  49 (2021)  2 - p. 179-190 , 2021
Link: https://doi.org/10.1007/..
 
?
12

A New Method to Model and Predict Progression Free Survival..:

Yu, Jiajie ; Wang, Nina ; Kågedal, Matts
CPT: Pharmacometrics & Systems Pharmacology.  9 (2020)  3 - p. 177-184 , 2020
Link: https://doi.org/10.1002/..
 
?
13

Impact of Physiologically Based Pharmacokinetics, Populatio..:

Li, Chunze ; Chen, Shang‐Chiung ; Chen, Yuan...
The Journal of Clinical Pharmacology.  60 (2020)  S1 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
14

Confounding factors in exposure–response analyses and mitig..:

Kawakatsu, Sonoko ; Bruno, René ; Kågedal, Matts...
British Journal of Clinical Pharmacology.  87 (2020)  6 - p. 2493-2501 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Analysis of Longitudinal‐Ordered Categorical Data for Muscl..:

Lu, Tong ; Yang, Yujie ; Jin, Jin Y..
CPT: Pharmacometrics & Systems Pharmacology.  9 (2020)  2 - p. 96-105 , 2020
Link: https://doi.org/10.1002/..
 
1-15